[1]
“Structure-Based Design and Molecular Docking Analysis of Uridine-Based and Muraymycin C2 Inhibitors Targeting MraY Translocase in Clinical Isolates Pseudomonas aeruginosa: Molecular Docking Analysis ”, IJEBS, vol. 1, no. 4, pp. 1–28, Oct. 2026, doi: 10.63939/f4e8jf34.